For IKI-220 (flonicamid) a dossier was submitted by ISK Biosciences Europe SA to the French authorities on 23 December 2003 with an application to obtain its inclusion in Annex I to Directive 91/414/EEC.
ISK Biosciences Europe SA a introduit, le 23 décembre 2003, un dossier concernant l'IKI-220 (flonicamide) auprès des autorités françaises, en vue d'obtenir son inscription à l'annexe I de la directive 91/414/CEE.